Envafolimab Monotherapy or Envafolimab + CAPEOX as Neoadjuvant Therapy for Locally Advanced Colorectal Cancer

NCT06014372 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Colon Cancer
Neoadjuvant Therapy
Immunotherapy

Interventions

DRUG: Envafolimab
DRUG: CAPEOX

Sponsor

Sun Yat-sen University